Abstract:Alimentary Pharmacology & Therapeutics Symposium SeriesVolume 1, Issue 1 p. 26-32 Panel discussion: treatment approaches to control gastrointestinal risk and balance cardiovascular risks and benefits: proposals and recommendations J. M. SCHEIMAN, J. M. SCHEIMAN University of Michigan Medical Center, Ann Arbor, MI, USASearch for more papers by this authorB. CRYER, B. CRYER University of Texas Southwestern Medical School, Dallas VA Medical Center, Dallas, TX, USASearch for more papers by this authorM. ASAKA, M. ASAKA Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, JapanSearch for more papers by this authorF. BERENBAUM, F. BERENBAUM Faculty of Medicine Pierre and Marie Curie, Department of Rheumatology, Saint-Antoine Hospital, Paris, FranceSearch for more papers by this authorJ. BONNET, J. BONNET Cardiology and Vascular Diseases Department, Victor Segalen University, Bordeaux, FranceSearch for more papers by this authorF. K.-L. CHAN, F. K.-L. CHAN Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, ChinaSearch for more papers by this authorG. KREJS, G. KREJS Karl-Franzens University, Graz, AustriaSearch for more papers by this authorA. LANAS, A. LANAS Gastroenterology Department, HCU, Instituto Aragones de Ciencias de la Salud (Red C03/02), Zaragoza, SpainSearch for more papers by this authorA. WEAVER, A. WEAVER University of Nebraska Medical Center, Omaha, NE, USASearch for more papers by this authorF. ZERBIB, F. ZERBIB Department of Gastroenterology, Saint-Andre Hospital, Bordeaux, FranceSearch for more papers by this author J. M. SCHEIMAN, J. M. SCHEIMAN University of Michigan Medical Center, Ann Arbor, MI, USASearch for more papers by this authorB. CRYER, B. CRYER University of Texas Southwestern Medical School, Dallas VA Medical Center, Dallas, TX, USASearch for more papers by this authorM. ASAKA, M. ASAKA Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, JapanSearch for more papers by this authorF. BERENBAUM, F. BERENBAUM Faculty of Medicine Pierre and Marie Curie, Department of Rheumatology, Saint-Antoine Hospital, Paris, FranceSearch for more papers by this authorJ. BONNET, J. BONNET Cardiology and Vascular Diseases Department, Victor Segalen University, Bordeaux, FranceSearch for more papers by this authorF. K.-L. CHAN, F. K.-L. CHAN Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, ChinaSearch for more papers by this authorG. KREJS, G. KREJS Karl-Franzens University, Graz, AustriaSearch for more papers by this authorA. LANAS, A. LANAS Gastroenterology Department, HCU, Instituto Aragones de Ciencias de la Salud (Red C03/02), Zaragoza, SpainSearch for more papers by this authorA. WEAVER, A. WEAVER University of Nebraska Medical Center, Omaha, NE, USASearch for more papers by this authorF. ZERBIB, F. ZERBIB Department of Gastroenterology, Saint-Andre Hospital, Bordeaux, FranceSearch for more papers by this author First published: 26 August 2005 https://doi.org/10.1111/j.1746-6342.2005.00018.xCitations: 4Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume1, Issue1September 2005Pages 26-32 RelatedInformation

BJN Volume 112 Issue 5 Cover and Back Matter

BJN Volume 116 Issue 4 Cover and Back Matter

BJN Volume 104 Issue 3 Cover and Back Matter

Beneficial Effects Of Soluble Dietary Jerusalem Artichoke (Helianthus Tuberosus) In The Prevention Of The Onset Of Type 2 Diabetes And Non-Alcoholic Fatty Liver Disease In High-Fructose Diet-Fed Rats

Human Health Benefits through Daily Consumption of Jerusalem Artichoke (Helianthus tuberosus L.) Tubers

Contents Vol. 45, 2011

Panel Discussion: Treatment Approaches to Control Gastrointestinal Risk and Balance Cardiovascular Risks and Benefits: Proposals and Recommendations

Metabolic and Anti-Inflammatory Protective Properties of Human Enriched Serum Following Artichoke Leaf Extract Absorption: Results from an Innovative Ex Vivo Clinical Trial

Utilization of Jerusalem Artichoke (Helianthus tuberosus L.) Tuber as a Prebiotic and a Synbiotic

Prebiotic effects of Jerusalem artichoke prevent hepatic steatosis in young rats submitted to a Western diet

Vol. 116, February 2018

Nutritional value, bioactivity, and application potential of Jerusalem artichoke (Helianthus tuberosus L.) as a neotype feed resource

HBPD: Table of Contents Vol. 7, No. 4, 2008

Anti-Inflammatory Effects of Heliangin from Jerusalem Artichoke (Helianthus tuberosus) Leaves Might Prevent Atherosclerosis

New Perspectives on the Effect of Dandelion, Its Food Products and Other Preparations on the Cardiovascular System and Its Diseases

Administration of Jerusalem artichoke reduces the postprandial plasma glucose and glucose-dependent insulinotropic polypeptide (GIP) concentrations in humans

Antioxidant and α-glucosidase inhibitory ingredients identified from Jerusalem artichoke flowers

The Effect of Nitrogen Fertilization on Yield and Macronutrient Concentrations in Three Cultivars of Jerusalem Artichoke (Helianthus tuberosus L.)

The effects of Jerusalem artichoke and fermented soybean powder mixture supplementation on blood glucose and oxidative stress in subjects with prediabetes or newly diagnosed type 2 diabetes

The Phytochemical Ingredients and Therapeutic Potential of Cynara scolymus L.

An Overview of the Versatility of the Parts of the Globe Artichoke (Cynara scolymus L.), Its By-Products and Dietary Supplements